Researchers from the University of Barcelona and the August Pi y Sunyer Biomedical Research Institute (IDIBAPS) have shown ...

Researchers have identified a mechanism explaining why lung cancer treatments sometimes fall short: as early as the initial treatment stages, a small but resilient population of cancer cells can ...

titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report." In this case report ...